Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials

To evaluate the safety and efficacy of bremelanotide for the treatment of premenopausal women with hypoactive sexual desire disorder. METHODS: Two identical phase 3, randomized, double-blind, placebo-controlled, multicenter clinical trials (RECONNECT) evaluated the safety and efficacy of bremelanoti...

Descripción completa

Detalles Bibliográficos
Autores principales: Kingsberg, Sheryl A., Clayton, Anita H., Portman, David, Williams, Laura A., Krop, Julie, Jordan, Robert, Lucas, Johna, Simon, James A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Contents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819021/
https://www.ncbi.nlm.nih.gov/pubmed/31599840
http://dx.doi.org/10.1097/AOG.0000000000003500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819021/
https://www.ncbi.nlm.nih.gov/pubmed/31599840
http://dx.doi.org/10.1097/AOG.0000000000003500

Ejemplares similares